|
|
| HITRIplus Newsletter |
| November 2023 |
|
|
|
|
Dear Readers,
In this issue, we are pleased to present an in-depth exploration of the recent IAEA-CNAO workshop, an event that has contributed to the ongoing advancements in the field of hadrontherapy. This workshop brought together leading experts to share their insights and foster collaborative advancements in cancer treatment. We invite you to delve into the key discussions and innovative perspectives highlighted during this important gathering.
Your continued interest and engagement in the rapidly evolving landscape of hadrontherapy are greatly appreciated, and we are committed to keeping you informed of these critical developments.
The HITRIplus Communications Team |
|
|
|
|
 |
| Here are concise summaries of some of the numerous key presentations from the recent event that showcase the forefront of innovation and collaboration in their respective fields |
|
|
|
|
|
 |
| Synergizing Science and Industry: The Pivotal Role of Intellectual Property in Advancing Medical Technology |
| Manuela Cirilli from CERN, "Academia Meets Industry: Intellectual Property, Communication, Managing Expectations," highlighted the symbiotic relationship between academic research and industrial application. Cirilli emphasized the importance of mutual benefits in such collaborations, specifically through the lens of technology transfer to achieve public good and stimulate economic growth. Intellectual Property (IP) rights play a crucial role in protecting and enabling the transfer of academic inventions to the marketplace, thus fostering innovation and generating revenue to reinvest in research. |
|
|
|
|
| Charting the Future of Ion Beam Therapy: Prof. Mairani's Vision of Modernized Treatment |
| Prof. Dr. Andrea Mairani from the Heidelberg Ion Beam Therapy Center, associated with the University Clinic Heidelberg and the German Cancer Research Center, delivered an insightful presentation on "Novel Approaches in Particle Therapy." He discussed the advancement of ion beam therapy through innovative technology, highlighting the importance of Fast Monte Carlo calculations for precision in treatment modalities. Dr. Mairani explored helium ion therapy's promising clinical applications, including improved dose distributions and reduced scattering effects. The presentation also covered the ARTEMIS program, which pioneers MR-guided Helium ion therapy for enhanced treatment efficacy. |
|
|
|
|
 |
| Advancements in Hadron Therapy for CNS Tumors: Insights from Semi Harrabi's Presentation at the Heidelberg Ion Beam Therapy Center |
| In the presentation titled "Central Nervous System Tumours" by Dr. Semi Harrabi from the Heidelberg Ion Beam Therapy Center at the University Hospital Heidelberg, Department of Radiation Oncology, key aspects of oncological dilemmas and the effectiveness of hadron therapy for brain tumors were discussed. The focus was on the eradication of all tumor cells, achieving local control, and improving survival while simultaneously protecting surrounding healthy tissue, preserving organs, and reducing late sequelae. The presentation highlighted the importance of establishing new treatment approaches or maximizing the benefits of established concepts to widen the therapeutic window in cancer treatment. |
|
|
|
|
 |
| Innovations in Particle Therapy: Exploring the Future of Ion Gantries with Marco Pullia |
| In the presentation "Ion Gantries" by Prof. Marco Pullia from CNAO Foundation, the focus was on the development and importance of gantries in particle therapy, especially in treating cancer with ion beams. Pullia discussed how gantries enable directing the therapeutic beam from any angle around the patient, enhancing treatment effectiveness and safety. He emphasized the large size and complexity of gantries for particle therapy compared to conventional radiotherapy, particularly for carbon ion therapy due to larger magnetic rigidity requirements. |
|
|
|
|
|
You receive this email as you subscribed to HITRIplus general newsletter in order to receive, via email, information and news about the activities of the HITRIplus Project, including invitations to participate in events or surveys and fundraising campaigns.
You can read more information about this data processing here: https://www.hitriplus.eu/privacy_policy/7410/
You can always opt-out selecting the unsubscribe option above.
petya.n.georgieva@gmail.com
©2023 HITRIplus |
|
|
|
